Skip to main content
EVENT REGISTRATION LOGIN
|
STAFF LOGIN
|
Mountain Navigation
About Us
Partners
Alaska
Colorado
Idaho
Montana
North & South Dakota
Oregon
Utah
Washington
Wyoming
Programs
AIDS Clinical Conference
Corrections
MWAETC HIV ECHO
Preceptorships
Practice Transformation
Interprofessional Education Project (IPE) Program
Diversity, Equity, and Inclusivity Initiatives
Dental Program
MWAETC On-Demand
Resources
Clinical Consultations & Guidelines
Service Locators & Referrals
General HIV Info Lines/Tool Kits/Resources
Population Specific
Co-Morbidities
Online Self-Service Learning - HIV/HBV/HCV/STD
Calendar
Jobs
Contact Us
For Participants
Search
Contact navigation
Regional Office
Alaska
Colorado
Idaho
Montana
North and South Dakota
Oregon
Utah
Washington
Wyoming
Regional Contacts
OD presentation return node
« Return to MWAETC On-Demand Presentations
menu title
Implementing Cabotegravir/Rilpivirine (Cabenuva)
« Return to MWAETC On-Demand Presentations
Implementing Cabotegravir/Rilpivirine (Cabenuva)
Presentation Date:
2022-06-23
Presentation Length:
22:03
Presenters:
Ji Eun Lee, PharmD, BCPS
Presentation Categories:
HIV ECHO
Presentation Tags:
Long- Acting ART/Injectables
,
Adherence
Presentation Slides:
Download (1.789 MB)
Presentation Downloads:
Related Documents:
Related Links:
Related Presentations:
Presentation Details:
Ji Lee, PharmD, discusses practical considerations for obtaining and administering long-acting, intramuscular, cabotegravir-rilpivirine for HIV treatment.
Presentation Transcript: